These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22421113)

  • 41. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--Part I.
    Safai B
    Clin Bull; 1977; 7(3):91-7. PubMed ID: 308870
    [No Abstract]   [Full Text] [Related]  

  • 42. Longterm remission of tumor-stage mycosis fungoides following total-skin electron-beam radiotherapy.
    Stallmeister T; Dieckmann K; Rehberger A; Jurecka W
    Eur J Dermatol; 1998 Jun; 8(4):240-2. PubMed ID: 9649676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
    Hagedorn M; Hasche E; Kober B; Sander CA
    Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
    Trautinger F; Knobler R; Willemze R; Peris K; Stadler R; Laroche L; D'Incan M; Ranki A; Pimpinelli N; Ortiz-Romero P; Dummer R; Estrach T; Whittaker S
    Eur J Cancer; 2006 May; 42(8):1014-30. PubMed ID: 16574401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mycosis fungoides--the practionner confronted with the nosological, diagnostic and prognostic problems of epidermotrophic lymphomas (author's transl)].
    Puissant A; Durepaire RM; Tousch MA; Delanoe J; Saurat JH
    Dermatologica; 1978; 157(6):365-70. PubMed ID: 720716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.
    Kaye FJ; Bunn PA; Steinberg SM; Stocker JL; Ihde DC; Fischmann AB; Glatstein EJ; Schechter GP; Phelps RM; Foss FM
    N Engl J Med; 1989 Dec; 321(26):1784-90. PubMed ID: 2594037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cutaneous T-cell lymphoma first presenting at the tumor stage. A clinicopathologic study.
    Schewach-Millet M; Azizi E; Semah D; Bubis JJ; Chaitchuk S
    Int J Dermatol; 1984 May; 23(4):275-8. PubMed ID: 6735555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Problems in the management of mycosis fungoides in Nigeria.
    Campbell OB; George AO; Shokunbi WA; Akang EE; Aghadiuno PU
    Trop Geogr Med; 1991 Jul; 43(3):317-22. PubMed ID: 1816671
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mycosis fungoides.
    Vázquez Botet M; Sánchez JL
    Bol Asoc Med P R; 1980 Apr; 72(4):188-91. PubMed ID: 6930976
    [No Abstract]   [Full Text] [Related]  

  • 50. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
    Ahmad K; Rogers S; McNicholas PD; Collins P
    Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathological Manifestations of Ichthyosiform Mycosis Fungoides.
    Jang MS; Kang DY; Park JB; Han SH; Lee KH; Kim JH; Ko JW; Suh KS
    Acta Derm Venereol; 2016 Jan; 96(1):100-1. PubMed ID: 26062766
    [No Abstract]   [Full Text] [Related]  

  • 52. Pautrier Microabscess: A Topic of Great Controversy.
    Giessinger J; LeBoit PE; Cribier B
    Am J Dermatopathol; 2021 Nov; 43(11):848-849. PubMed ID: 34387195
    [No Abstract]   [Full Text] [Related]  

  • 53. Cutaneous T-cell lymphoma.
    Eddy JL; Selgas-Cordes R; Curran M
    Am J Nurs; 1984 Feb; 84(2):202-6. PubMed ID: 6559537
    [No Abstract]   [Full Text] [Related]  

  • 54. The management of minimal extent mycosis fungoides.
    Rotstein H
    Int J Dermatol; 1983 Nov; 22(9):515-7. PubMed ID: 6642841
    [No Abstract]   [Full Text] [Related]  

  • 55. Cytokine signaling pathways as molecular markers of the efficacy of phototherapy in early stages of mycosis fungoides.
    Vorontsova AA; Karamova AE; Nikonorov AA; Kozlova IV; Nikonorova ER; Kubanov AA
    Arch Dermatol Res; 2024 Apr; 316(5):127. PubMed ID: 38662241
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of refractory stage IV mycosis fungoides with bexarotene monotherapy.
    Otremba B
    Dermatol Clin; 2008 Jan; 26 Suppl 1():51-2. PubMed ID: 18405188
    [No Abstract]   [Full Text] [Related]  

  • 57. [Early morphological signs of mycosis fungoides].
    Persina IS; Kalamkarian AA; Zabanova EV; Averbakh EV
    Vestn Dermatol Venerol; 1988; (1):4-8. PubMed ID: 3364020
    [No Abstract]   [Full Text] [Related]  

  • 58. Hyperacute graft-versus-host disease after bone marrow transplantation for mycosis fungoides.
    Takahashi T; Fujimoto N; Kito K; Tanaka T
    J Dermatol; 2015 Mar; 42(3):327-8. PubMed ID: 25571971
    [No Abstract]   [Full Text] [Related]  

  • 59. Reduced-intensity conditioning followed by cord blood transplantation in a patient with refractory folliculotropic mycosis fungoides.
    Nakaike T; Kato K; Oku S; Hayashi M; Kikushige Y; Kuroiwa M; Takenaka K; Iwasaki H; Miyamoto T; Teshima T; Ohshima K; Akashi K
    Int J Hematol; 2013 Oct; 98(4):491-5. PubMed ID: 23943312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real-life use of phototherapy in early-stage mycosis fungoides from the Cutaneous Lymphoma Commission of the Italian Lymphoma Foundation: results of a web-based survey.
    Grandi V; Fava P; Rupoli S; Alberti Violetti S; Canafoglia L; Berti E; Quaglino P; Pimpinelli N;
    G Ital Dermatol Venereol; 2018 Oct; 153(5):745-746. PubMed ID: 29144101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.